Pioglitazone and Lower Risk of Dementia: Will This Change Practice?

Colleen J. Maxwell, Wajd Alkabbani, Sevil Yasar

Research output: Contribution to journalReview articlepeer-review

Abstract

Globally, more than 536 million people live with diabetes (primarily type 2 diabetes mellitus [T2DM]), and this estimate is projected to increase to 783 million by 2045.1 As this population ages, many will experience vascular complications including stroke and dementia.2,3 Over the coming decades, the prevalence of each condition and related disability and comorbidity is projected to increase substantially because of population aging, rising obesity prevalence at younger ages, earlier disease detection and diagnosis, and increased survival rates.1,4

Original languageEnglish (US)
Pages (from-to)803-804
Number of pages2
JournalNeurology
Volume100
Issue number17
DOIs
StatePublished - Apr 25 2023

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint

Dive into the research topics of 'Pioglitazone and Lower Risk of Dementia: Will This Change Practice?'. Together they form a unique fingerprint.

Cite this